Cart
sales@molnova.com
Testosterone Phenylpropionate
CAS No. 1255-49-8
Testosterone Phenylpropionate( NSC 22643 | Testosterone 17-phenylpropionate )
Catalog No. M11038 CAS No. 1255-49-8
Testosterone Phenylpropionate has an active life of 4-5 day. Release time-wise, it is directly in the middle of the Propionate (short) and Cypionate (long) versions of Testosterone.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameTestosterone Phenylpropionate
-
NoteResearch use only, not for human use.
-
Brief DescriptionTestosterone Phenylpropionate has an active life of 4-5 day. Release time-wise, it is directly in the middle of the Propionate (short) and Cypionate (long) versions of Testosterone.
-
DescriptionTestosterone Phenylpropionate has an active life of 4-5 day. Release time-wise, it is directly in the middle of the Propionate (short) and Cypionate (long) versions of Testosterone.
-
In Vitro——
-
In Vivo——
-
SynonymsNSC 22643 | Testosterone 17-phenylpropionate
-
PathwayEndocrinology/Hormones
-
TargetAndrogen Receptor (AR)
-
RecptorAndrogen Receptor
-
Research AreaOther Indications
-
Indication——
Chemical Information
-
CAS Number1255-49-8
-
Formula Weight420.58
-
Molecular FormulaC28H36O3
-
Purity>98% (HPLC)
-
SolubilityDMSO: 10 mM
-
SMILESC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2OC(=O)CCC4=CC=CC=C4)CCC5=CC(=O)CC[C@]35C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Jakubovic A, Cekan Z. Acta Endocrinol (Copenh). 1967 Oct;56(2):197-202.
molnova catalog
related products
-
Zanoterone
Zanoterone is an AR antagonist (androgen receptor).Zanoterone has antitumor activity for the treatment of genitourinary disorders and oncological disorders and may be used in the study of prostate cancer.
-
AZD3514
AZD3514 is a potent and oral androgen receptor downregulator with Ki of 2.2 μM and has ability of reducing AR protein expression.Phase 1.
-
VPC-13566
VPC-13566 is a BF3-specific small molecule, which effectively inhibited the androgen receptor transcriptional activity and displaced the BAG1L peptide from the BF3 pocket.
